Wells Fargo Upgrades Edwards Lifesciences (EW) to Outperform; Final TAVR NCD A Win, More Catalysts To Follow
Go back to Wells Fargo Upgrades Edwards Lifesciences (EW) to Outperform; Final TAVR NCD A Win, More Catalysts To Follow| Edwards Lifesciences (NYSE: EW) | Delayed: 91.44 -0.84 (0.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.28 | 52 Week High | $166.87 | |||
| Open | $91.61 | 52 Week Low | $72.20 | |||
| Day High | $92.27 | P/E | 26.58 | |||
| Day Low | $90.84 | EPS | $3.44 | |||
| Volume | 488,782 | |||||
